🚀 VC round data is live in beta, check it out!
Nightingale Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for Nightingale Health and similar public comparables like Senzime, Research Solutions, Health Catalyst, Champions Oncology and more.
Nightingale Health Overview
About Nightingale Health
Nightingale Health PLC offers a health data platform that detects disease risks. The Health Data Platform empowers individuals to take actions to prevent diseases by allowing them access to disease risk information. With its Health Data Platform, the company connects the services of healthcare actors with the preventative health needs of individuals. The company operates in Finland, Japan, the United Kingdom, Singapore, and the USA.
Founded
2002
HQ
Employees
95
Website
Financials (LTM)
EV
$46M
Nightingale Health Financials
Nightingale Health reported last 12-month revenue of $8M and negative EBITDA of ($12M).
In the same LTM period, Nightingale Health generated ($12M) in EBITDA losses.
Revenue (LTM)
Nightingale Health P&L
In the most recent fiscal year, Nightingale Health reported revenue of $6M and EBITDA of ($12M).
Nightingale Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $8M | XXX | $6M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $4M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 75% | XXX | XXX | XXX |
| EBITDA | ($12M) | XXX | ($12M) | XXX | XXX | XXX |
| EBITDA Margin | (147%) | XXX | (215%) | XXX | XXX | XXX |
| EBIT Margin | (246%) | XXX | (413%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($22M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (393%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Nightingale Health Stock Performance
Nightingale Health has current market cap of $91M, and enterprise value of $46M.
Market Cap Evolution
Nightingale Health's stock price is $1.50.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $46M | $91M | 0.2% | XXX | XXX | XXX | $-0.36 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNightingale Health Valuation Multiples
Nightingale Health trades at 5.6x EV/Revenue multiple, and (3.8x) EV/EBITDA.
EV / Revenue (LTM)
Nightingale Health Financial Valuation Multiples
As of April 18, 2026, Nightingale Health has market cap of $91M and EV of $46M.
Equity research analysts estimate Nightingale Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Nightingale Health has a P/E ratio of (4.2x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $91M | XXX | $91M | XXX | XXX | XXX |
| EV (current) | $46M | XXX | $46M | XXX | XXX | XXX |
| EV/Revenue | 5.6x | XXX | 8.3x | XXX | XXX | XXX |
| EV/EBITDA | (3.8x) | XXX | (3.9x) | XXX | XXX | XXX |
| EV/EBIT | (2.3x) | XXX | (2.0x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 11.0x | XXX | XXX | XXX |
| P/E | — | XXX | (4.2x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (2.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Nightingale Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Nightingale Health Margins & Growth Rates
Nightingale Health's revenue in the last 12 month grew by 27%.
Nightingale Health's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.3M for the same period.
Nightingale Health's rule of 40 is (73%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Nightingale Health's rule of X is (18%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Nightingale Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 27% | XXX | 61% | XXX | XXX | XXX |
| EBITDA Margin | (147%) | XXX | (215%) | XXX | XXX | XXX |
| EBITDA Growth | (15%) | XXX | (0%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (73%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (18%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 20% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 54% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 489% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Nightingale Health Public Comps
See public comps and valuation multiples for other Health Data & Analytics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Nightingale Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Senzime | XXX | XXX | XXX | XXX | XXX | XXX |
| Research Solutions | XXX | XXX | XXX | XXX | XXX | XXX |
| Health Catalyst | XXX | XXX | XXX | XXX | XXX | XXX |
| Champions Oncology | XXX | XXX | XXX | XXX | XXX | XXX |
| Revium Recovery | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nightingale Health M&A Activity
Nightingale Health acquired XXX companies to date.
Last acquisition by Nightingale Health was on XXXXXXXX, XXXXX. Nightingale Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Nightingale Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNightingale Health Investment Activity
Nightingale Health invested in XXX companies to date.
Nightingale Health made its latest investment on XXXXXXXX, XXXXX. Nightingale Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Nightingale Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Nightingale Health
| When was Nightingale Health founded? | Nightingale Health was founded in 2002. |
| Where is Nightingale Health headquartered? | Nightingale Health is headquartered in Finland. |
| How many employees does Nightingale Health have? | As of today, Nightingale Health has over 95 employees. |
| Is Nightingale Health publicly listed? | Yes, Nightingale Health is a public company listed on Nasdaq Helsinki. |
| What is the stock symbol of Nightingale Health? | Nightingale Health trades under HEALTH ticker. |
| When did Nightingale Health go public? | Nightingale Health went public in 2021. |
| Who are competitors of Nightingale Health? | Nightingale Health main competitors are Senzime, Research Solutions, Health Catalyst, Champions Oncology. |
| What is the current market cap of Nightingale Health? | Nightingale Health's current market cap is $91M. |
| What is the current revenue of Nightingale Health? | Nightingale Health's last 12 months revenue is $8M. |
| What is the current revenue growth of Nightingale Health? | Nightingale Health revenue growth (NTM/LTM) is 27%. |
| What is the current EV/Revenue multiple of Nightingale Health? | Current revenue multiple of Nightingale Health is 5.6x. |
| Is Nightingale Health profitable? | No, Nightingale Health is not profitable. |
| What is the current EBITDA of Nightingale Health? | Nightingale Health has negative EBITDA and is not profitable. |
| What is Nightingale Health's EBITDA margin? | Nightingale Health's last 12 months EBITDA margin is (147%). |
| What is the current EV/EBITDA multiple of Nightingale Health? | Current EBITDA multiple of Nightingale Health is (3.8x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.